# Simvastatin Nasal Rinses for the Treatment of COVID-19 Mediated Dysomsia

> **NCT05542095** · PHASE1 · WITHDRAWN · sponsor: **Washington University School of Medicine**

## Conditions studied

- Olfactory Disorder
- COVID-19

## Interventions

- **DRUG:** Simvastatin

## Key facts

- **NCT ID:** NCT05542095
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-05-01
- **Primary completion:** 2023-05-01
- **Final completion:** 2023-05-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study halted prematurely; IRB approval not obtained
- **Last updated:** 2023-06-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05542095

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05542095, "Simvastatin Nasal Rinses for the Treatment of COVID-19 Mediated Dysomsia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05542095. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*